Health Trials

Renal Clear Cell Carcinoma

2

Review clinical trials related to Renal Clear Cell Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CD70-targeted immunoPET Imaging of Malignant Cancers

This study aims to determine the value of cluster of differentiation (CD70)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging for diagnosing human malignancies, including renal cell carcinoma (particularly clear cell renal cell carcinoma), lymphoma, and nasopharyngeal carcinoma (NPC), among others.

Participants needed: 300
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: RenJi HospitalUpdated: May 12, 2026Locations: 1
Eligibility criteria

Aged 18-80 year-old and of either sex； [+2]

Pregnancy； [+2]

Read more
Status: Recruiting

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

Based on different subtypes, subjects will be placed in one of three treatment groups to explore individual efficacy and safety of various treatment regimen.

Participants needed: 66
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Jan 18, 2024Locations: 1
Eligibility criteria

Male or female aged 18 and ≤ 75; [+8]

Radiation, surgery, chemotherapy, immunotherapy or molecular targeted therapy fo... [+17]

Read more